Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.
If you were prescribed this medicine, other products containing Iodine, Potassium iodide may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.
this medicine Apply it to the skin.
Iodine Tincture contains iodine which is an antiseptic. It is for use on minor wounds, cuts and scrapes.
Adults, the elderly and children
If you notice these or any other side effect not included above, stop use and tell your doctor or pharmacist. They will tell you what to do. Reporting of side effects If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard By reporting side effects you can help provide more information on the safety of this medicine.
Turn over
Fonts Used
23701703
5. Storing this medicine
Colours Used
Iodine Tincture
Leaflet
25ml
23701703
210 x 148mm flat (27 x 148mm folded)
Product Title
Component
Pack Size
IG Code
Dimensions
6. Further information What is in this medicine
The active ingredients are: iodine 2.5% w/v, potassium iodide 2.5% w/v. The other ingredients are: purified water and ethanol 89% v/v.
What the medicine looks like
Iodine Tincture is a dark brown liquid which smells of alcohol. It is supplied in 25ml bottles.
Marketing authorisation holder and L.C.M. Ltd., Huddersfield, HD7 5QH, UK.
Colours Used
Iodine Tincture Product Title This leaflet was last revised in February 2015
Process Black
Component
Leaflet
Pack Size
25ml
IG Code
23701703
Dimensions
210 x 148mm flat (27 x 148mm folded)
Proof No.
1
Date
20.01.2015
Helvetica
23701703
Approved by Date
jade.cerff
Artwork No 553555 Suf fix
CRN
11850
Reason for Change
Addition of reporting of side effects statement
A
Issued by Date
MHRA/IMB submission Yes required
Fonts Used
Keylines
PCP Header Box Operator
MHRA Header Box
MHRA Header Box manufacturer
20.01.2015
Now read the rest of the leaflet before you use this medicine. It includes other information which might be especially important for you.
Date
you or your child are having….
Like all medicines, Iodine Tincture can have side effects, although these don't affect everyone. Allergic reactions may occur including:
1
Talk to your doctor or pharmacist if
Proof No.
Do not use….
Keylines
If you accidentally swallow some see a doctor straight away. Take the pack with you to show which medicine you have swallowed.
Data Matrix: 23701703 VERIFIED
Do not use the medicine if you or your child have….
Important information about Iodine Tincture
If you swallow some
Helvetica
2. Before you use this medicine
Process Black
Iodine Tincture
(iodine, potassium iodide)
The active substance in Iodine Tincture BP is iodine, potassium iodide.
This leaflet reproduces the patient information leaflet approved for Iodine Tincture BP, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.
Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.
The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.
As an antiseptic for use on minor wounds, cuts and abrasions.
For cutaneous use.The product is suitable for use by adults, children and the elderly.Apply to the affected part with cotton wool or a small brush.
Contraindicated for patients hypersensitive to iodine or iodides.Contradicted for use in newborn infants.Contradicted in patients with thyroid disorders or those receiving lithium therapy.
Avoid prolonged use.For external use only.Keep all medicines out of the reach and sight of children.Solutions of iodine applied to the skin should not be covered with occlusive dressings, (otc packs to state the shortened warning, “ DO NOT COVER” ).Do not use on large, open wounds.
Administration of this product may interfere with tests of thyroid function.
Use with caution during pregnancy and lactation. Iodides cross the placenta and are excreted in breast milk.
None or negligible influence.
May cause allergic reactions, including urticaria, angioedema, cutaneous haemorrhage or purpuras, fever, arthralgia, lymphadenopathy and eosinophilia. Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard.
This product is not intended for internal use.Symptoms of acute poisoning from ingestion of iodine include a disagreeable metallic taste, vomiting, abdominal pain and diarrhoea, thirst and headache may occur. The fatal dose of iodine is 2 to 3g. Symptomatic treatment for allergic reactions and iodism may be required, although symptoms usually subside rapidly when administration of iodine or iodide is stopped.In acute poisoning copious draughts of milk and starch mucilage should be given. Lavage should probably not be attempted and certainly not unless iodine had been ingested in sufficiently dilute form not to produce gastrointestinal corrosion. Other treatments include activated charcoal and sodium thiosulphate solution 1% or 5% to reduce iodine to the less toxic iodides. Electrolyte and water losses should be replaced and the circulation should be maintained. Pethidine or morphine sulphate may be given for pain, under medical supervision. A tracheotomy may become necessary.Provided the product is not applied to large, open wounds or used for prolonged periods, clinically significant systemic absorption is unlikely. Systemic toxicity may lead to shock, tachycardia, fever, metabolic acidosis and renal impairment Death may be due to circulatory failure, oedema of the epiglottis resulting in asphyxia, aspiration pneumonia or pulmonary oedema. Oesophageal stricture may occur if the patient survives the acute stage.
Medicines sold in Poland with the same active substance: W Polsce znany jako
⚠ Not the same combination. This medicine contains Iodine, Potassium iodide. The products below do not contain exactly the same set of active substances — they are not direct substitutes.
⚠ Same active substance, but a different pharmaceutical form (for example a gel instead of a tablet). Not interchangeable — ask a pharmacist.
Some of these do not contain exactly the same active substances — check each one. The strength, the form and whether you need a prescription can differ. Always ask a pharmacist before you switch. Polish medicines in the UK →
Ask anything about Iodine Tincture BP. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.
Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.
We use essential cookies to make the site work. We would also like to set optional cookies to understand how the site is used, so we can improve it. We will not set optional cookies unless you accept. See our cookie policy and privacy policy.